| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9101592 | POHL BOSKAMP | Stabilized granules containing glyceryl trinitrate |
Mar, 2032
(8 years from now) | |
Gonitro is owned by Pohl Boskamp.
Gonitro contains Nitroglycerin.
Gonitro has a total of 1 drug patent out of which 0 drug patents have expired.
Gonitro was authorised for market use on 08 June, 2016.
Gonitro is available in powder;sublingual dosage forms.
The generics of Gonitro are possible to be released after 11 March, 2032.
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 08 June, 2016
Treatment: NA
Dosage: POWDER;SUBLINGUAL
More Information on Dosage
GONITRO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic